Your browser doesn't support javascript.
loading
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.
Singh, Simron; Hope, Thomas A; Bergsland, Emily B; Bodei, Lisa; Bushnell, David L; Chan, Jennifer A; Chasen, Beth R; Chauhan, Aman; Das, Satya; Dasari, Arvind; Del Rivero, Jaydira; El-Haddad, Ghassan; Goodman, Karyn A; Halperin, Daniel M; Lewis, Mark A; Lindwasser, O Wolf; Myrehaug, Sten; Raj, Nitya P; Reidy-Lagunes, Diane L; Soares, Heloisa P; Strosberg, Jonathan R; Kohn, Elise C; Kunz, Pamela L.
Affiliation
  • Singh S; Department of Medicine, Sunnybrook Health Sciences Centre, Odette Cancer Center, University of Toronto, Toronto, ON, Canada.
  • Hope TA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
  • Bergsland EB; Department of Medicine, University of California, San Francisco, CA, USA.
  • Bodei L; Department of Radiology, Memorial Sloan Kettering Cancer Center, Molecular Imaging and Therapy Service, New York, NY, USA.
  • Bushnell DL; Department of Radiology, University of Iowa, Iowa City, IA, USA.
  • Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Chasen BR; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chauhan A; Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.
  • Das S; Late-Stage Development, Oncology R&D AstraZeneca, Gaithersburg, MD, USA.
  • Dasari A; Department of GI Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Del Rivero J; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • El-Haddad G; Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Goodman KA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA.
  • Halperin DM; Department of GI Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lewis MA; Department of Medicine, Intermountain Health, Salt Lake City, UT, USA.
  • Lindwasser OW; Coordinating Center for Clinical Trials, National Cancer Institute, Bethesda, MD, USA.
  • Myrehaug S; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Center, Toronto, ON, Canada.
  • Raj NP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Reidy-Lagunes DL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Soares HP; Department of Medicine, Huntsman Cancer Institute at University of Utah, Salt Lake City, UT, USA.
  • Strosberg JR; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Kohn EC; National Cancer Institute, Bethesda, MD, USA.
  • Kunz PL; Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
J Natl Cancer Inst ; 115(9): 1001-1010, 2023 09 07.
Article in En | MEDLINE | ID: mdl-37255328
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors / Intestinal Neoplasms Type of study: Guideline Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors / Intestinal Neoplasms Type of study: Guideline Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article